Owens & Minor (OMI) Stock Price, News & Analysis

Company Overview

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers. Its portfolio of medical and surgical supplies includes branded products and its proprietary products. This segment also offers services to healthcare providers, including supplier management, analytics, inventory management, and clinical supply management; and various programs to provide outsourced logistics and marketing solutions to its suppliers. The Patient Direct segment provides products and services for in-home care and delivery across diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment. This segment supplies a range of other home medical equipment, patient care products, including ostomy, wound care, urology, incontinence and other products and services. It serves multi-facility networks of healthcare providers, independent hospitals, surgery centers, physicians' practices, and networks of hospitals directly, as well as indirectly through third-party distributors. Owens & Minor, Inc. was founded in 1882 and is headquartered in Richmond, Virginia.

Key Stats

• Today's Range: $11.78 to $12.16
• 50-Day Range: $11.78 to $16.18
• 52-Week Range: $11.42 to $28.35
• Volume: 56,767 shs
• Average Volume: 824,757 shs
• Market Capitalization: $924.55 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $18.50
• Consensus Rating: Hold

Owens & Minor Stock Analysis - MarketRank™

Owens & Minor scored higher than 95% of companies evaluated by MarketBeat, and ranked 81st out of 952 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.0 / 5
• Analyst Rating: Hold

Consensus Rating

Owens & Minor has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on 2 buy ratings, 4 hold ratings, and 2 sell ratings.

Amount of Analyst Coverage

Owens & Minor has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 23.49%

Earnings Growth

Earnings for Owens & Minor are expected to grow by 23.49% in the coming year, from $1.49 to $1.84 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Owens & Minor is -18.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Owens & Minor is -18.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Owens & Minor has a PEG Ratio of 0.43. PEG Ratios below 1 indicate that a company could be undervalued.

Price to Book Value per Share Ratio

Owens & Minor has a P/B Ratio of 1.07. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

5.92% of the float of Owens & Minor has been sold short.

Short Interest Ratio / Days to Cover

Owens & Minor has a short interest ratio ("days to cover") of 4.6.

Change versus previous month

Short interest in Owens & Minor has recently decreased by 12.34%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Owens & Minor does not currently pay a dividend.

Dividend Growth

Owens & Minor does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.9 / 5
• Environmental Score: -1.52

Percentage of Shares Shorted

5.92% of the float of Owens & Minor has been sold short.

Short Interest Ratio / Days to Cover

Owens & Minor has a short interest ratio ("days to cover") of 4.6.

Change versus previous month

Short interest in Owens & Minor has recently decreased by 12.34%, indicating that investor sentiment is improving significantly.

News and Social Media

• Score: 3.3 / 5
• News Sentiment: 0.88

News Sentiment

Owens & Minor has a news sentiment score of 0.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.47 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Owens & Minor this week, compared to 4 articles on an average week.

Search Interest

3 people have searched for OMI on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added Owens & Minor to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Owens & Minor insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 3.59% of the stock of Owens & Minor is held by insiders.

Percentage Held by Institutions

98.04% of the stock of Owens & Minor is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

OMI Stock Analysis - Frequently Asked Questions

How have OMI shares performed this year?

Owens & Minor's stock was trading at $19.27 at the beginning of 2024. Since then, OMI shares have decreased by 36.9% and is now trading at $12.16.
View the best growth stocks for 2024 here.

How were Owens & Minor's earnings last quarter?

Owens & Minor, Inc. (NYSE:OMI) issued its earnings results on Monday, November, 4th. The company reported $0.42 earnings per share for the quarter, beating analysts' consensus estimates of $0.41 by $0.01. The firm's revenue for the quarter was up 5.0% compared to the same quarter last year.

Does Owens & Minor have any subsidiaries?

Owens & Minor subsidiaries include Halyard Health - S&IP, Byram Healthcare Centers, ArcRoyal, Medical Action Industries, Movianto, The Burrows Company, McKesson's Acute-Care Medical, and others.

Who are Owens & Minor's major shareholders?

Owens & Minor's top institutional shareholders include FMR LLC (15.00%), State Street Corp (3.97%), Charles Schwab Investment Management Inc. (2.63%) and Geode Capital Management LLC (2.22%). Insiders that own company stock include Edward A Pesicka, Jeffrey T Jochims, Perry A Bernocchi, Jonathan A Leon, Michael Wayne Lowry, Snehashish Sarkar, Heath H Galloway, Alexander J Bruni, Robert J Henkel, Gwendolyn M Bingham, Mark A Beck and Louis Emmanuel Castro.
View institutional ownership trends.

How do I buy shares of Owens & Minor?

Shares of OMI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Owens & Minor own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Owens & Minor investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

• Last Earnings: 11/04/2024
• Today: 11/21/2024
• Fiscal Year End: 12/31/2024
• Next Earnings (Estimated): 2/18/2025

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical & hospital equipment
• Sub-Industry: Health Care Distributors
• Current Symbol: NYSE:OMI
• CUSIP: 69073210
• CIK: 75252
• Web: www.owens-minor.com
• Phone: (804) 723-7000
• Fax: 804-723-7100
• Employees: 13,700
• Year Founded: 1882

Price Target and Rating

• Average Stock Price Target: $18.50
• High Stock Price Target: $25.00
• Low Stock Price Target: $14.00
• Potential Upside/Downside: +55.6%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 8 Analysts

Profitability

• EPS (Most Recent Fiscal Year): ($0.65)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 7.98
• P/E Growth: 0.42
• Net Income: $-41,300,000.00
• Net Margins: -0.46%
• Pretax Margin: -0.34%
• Return on Equity: 14.60%
• Return on Assets: 2.51%

Debt

• Debt-to-Equity Ratio: 2.11
• Current Ratio: 1.09
• Quick Ratio: 0.45

Sales & Book Value

• Annual Sales: $10.33 billion
• Price / Sales: 0.09
• Cash Flow: $4.97 per share
• Price / Cash Flow: 2.39
• Book Value: $12.08 per share
• Price / Book: 0.98

Miscellaneous

• Outstanding Shares: 77,110,000
• Free Float: 75,089,000
• Market Cap: $916.84 million
• Optionable: Optionable
• Beta: 0.41